Showing results (1231-1240 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|September 28, 2017
Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention studyNicola Dalbeth, Jordyn Allan, Gregory D Gamble, et al.
RMD Open|September 29, 2017
Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activityMelissa R Briones, Gabrielle A Morgan, Maria C Amoruso, et al.
RMD Open|September 29, 2017
Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive womenSabrina Meisgen, Joanna Tingström, Amanda Skog Andreasson, et al.
RMD Open|December 12, 2017
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trialPhilip J Mease, Arthur Kavanaugh, Laura C Coates, et al.
RMD Open|February 14, 2018
Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational studyRieke Alten, Xavier Mariette, Hanns-Martin Lorenz, et al.
RMD Open|February 14, 2018
Chronic but not inflammatory changes at the Achilles' tendon differentiate patients with peripheral spondyloarthritis from other diagnoses - Results from a prospective clinical trialXenofon Baraliakos, Uta Kiltz, Heiner Appel, et al.
RMD Open|February 14, 2018
Real-world burden of comorbidities in US patients with psoriatic arthritisKamal Shah, Maria Paris, Lillian Mellars, et al.
RMD Open|January 5, 2018
Synovial tissue macrophages: friend or foe?Mariola Kurowska-Stolarska, Stefano Alivernini
RMD Open|January 5, 2018
Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1Laura C Coates, Mitsumasa Kishimoto, Alice Gottlieb, et al.
RMD Open|March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritisDésirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.
Pageof 197